A March 2026 Inspire360 report identifies 17 fitness operators structuring GLP-1 programs through clinical partnerships, referral models, and in-club services involving provider-led prescribing and patient assessment. The report outlines service structures involving treatment planning, care delivery, and provider involvement.
Fitness Operators Deliver GLP-1 Programs Through Multiple Service Models
Seventeen fitness operators are delivering GLP-1 weight-loss programs through clinical partnerships, referral arrangements, and in-club service models, according to the Inspire360 GLP-1 Club Intelligence Report (Q1 2026). The March 2026 report outlines how clinical services are delivered under provider direction across these models. These programs involve services that require medical assessment and provider-directed care processes, including treatments also performed in Med Spa settings.
Inspire360 Report Outlines Weight-Loss Program Models Across Fitness Operators
The Inspire360 GLP-1 Club Intelligence Report (Q1 2026) identifies 17 fitness operators and 10 solution providers that have established weight-loss programs involving prescription medications as of March 2026. The findings include usage indicators showing that approximately 12.4% of U.S. adults have used a GLP-1 medication, with projections reaching up to 30 million users by 2030. Nearly half of these individuals also consider incorporating gym-based support into their care.
These programs are structured to distinguish medical services from fitness-based offerings, with licensed providers responsible for treatment delivery and operators managing program access and member engagement.
The report outlines several program models across multiple operators:
- Referral-based arrangements: Members are directed to external providers who conduct evaluations and facilitate prescribing.
- Telehealth partnerships: Licensed clinicians manage prescribing and follow-up care remotely, including programs supported by partnerships.
- White-label clinical platforms: Clinical services operate under the fitness brand while remaining provider-directed.
- Bundled programs: Medication access is combined with coaching, nutrition, and fitness services in a single program.
- In-club clinical services: Treatment is delivered on-site under the supervision of licensed providers.
Telehealth platforms support care delivery, monitoring, and coordination across these models, connecting providers and fitness operators within a single delivery structure. These arrangements assign clinical responsibilities to licensed providers, while operators manage program access, delivery, and member engagement.
Comparable service structures are used in men’s wellness clinics offering hormone and weight-loss services through provider-led intake and dedicated patient assessment.
Source Attribution
According to the Inspire360 GLP-1 Club Intelligence Report (Q1 2026), fitness operators are structuring weight-loss programs through referral models, telehealth partnerships, and in-club clinical services involving licensed providers.
Regulatory Requirements for GLP-1 Prescribing and Program Structure
Programs involving prescription-based weight-loss treatments must align with federal and state requirements governing prescribing, compounding, and provider relationships. GLP-1 medications are subject to standards related to patient-specific prescribing and limitations on compounded formulations.
In February 2026, the U.S. Food and Drug Administration (FDA) announced enforcement actions targeting compounded GLP-1 products marketed at scale. The agency also issued warning letters to telehealth companies for marketing practices it described as false or misleading, emphasizing that prescribing must be based on individualized patient needs and supported by appropriate documentation.
State laws governing referral arrangements and revenue-sharing between providers and non-medical businesses also apply to partnership-based program models, particularly where clinical services are coordinated through third-party providers.
The Inspire360 report also references the Centers for Medicare & Medicaid Services (CMS) BALANCE Model, announced in January 2026, which requires eligible patients to participate in structured lifestyle support programs as part of coverage pathways.
These requirements apply across referral-based, telehealth, and white-label program structures. Treatment decisions, patient assessment, and documentation must remain within provider-led workflows, consistent with telemedicine-based patient evaluation standards and medical director oversight requirements in outsourced exam models.
Practical Implications for Med Spa Operators
- Evaluate how weight-loss programs may be positioned alongside existing aesthetic and medical services.
- Define how care is coordinated between telehealth providers and on-site staff across treatment workflows.
- Ensure weight-loss programs operate under provider oversight when services involve prescription medications.
- Verify how medications are sourced and dispensed in alignment with requirements for compounded and FDA-approved products.
- Standardize program structures across locations when using partnerships or telehealth-based models.
What to Monitor in GLP-1 Program Models and Regulatory Activity
The Inspire360 report outlines program models combining clinical partnerships, referral pathways, and in-club services. Changes to how these models are implemented, including coordination with telehealth and external providers, may affect service delivery across Med Spa clinics.
About Spakinect
Spakinect provides compliance infrastructure and telehealth-supported supervision solutions for medical aesthetic practices. For additional information, see our website.
Image attribution: “Woman doing squat workout in gym with barbell” by Ivan Samkov, via Wikimedia Commons, licensed under CC BY 2.0.
